| Literature DB >> 26984536 |
Kate Keogh1,2, David A Kenny1, Paul Cormican1, Alan K Kelly2, Sinead M Waters3.
Abstract
BACKGROUND: Compensatory growth (CG) is an accelerated growth phenomenon observed in animals upon re-alimentation following a period of dietary restriction. It is typically utilised in livestock systems to reduce feed costs during periods of reduced feed availability. The biochemical mechanisms controlling this phenomenon, however, are yet to be elucidated. This study aimed to uncover the molecular mechanisms regulating the hepatic expression of CG in cattle, utilising RNAseq. RNAseq was performed on hepatic tissue of bulls following 125 days of dietary restriction (RES) and again following 55 days of subsequent re-alimentation during which the animals exhibited significant CG. The data were compared with those of control animals offered the same diet on an ad libitum basis throughout (ADLIB). Elucidation of the molecular control of CG may yield critical information on genes and pathways which could be targeted as putative molecular biomarkers for the selection of animals with improved CG potential.Entities:
Keywords: Cattle; Compensatory growth; Dietary restriction; Liver; RNAseq
Mesh:
Year: 2016 PMID: 26984536 PMCID: PMC4794862 DOI: 10.1186/s12864-016-2578-5
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Schematic representation of growth rate and weight gain of the experimental trial showing planned growth paths for ad libitum (ADLIB) and feed restricted-refed (RES) animals
Fig. 2Multi-dimensional scaling plot of hepatic transcript reads following a period of dietary restriction at the end of Period 1. Plot in which distance corresponds to the biological coefficient of variation, with clear separation of RES (blue) and ADLIB (red) treatment groups in gene transcript abundance reads following a period of restricted feeding at the end of Period 1
Fig. 3Multi-dimensional scaling plot of hepatic transcript reads following a period of compensatory growth at the end of Period 2. Plot in which distance corresponds to the biological coefficient of variation, with no clear separation between RES (blue) and ADLIB (red) treatment groups in gene transcript abundance reads following a period of compensatory growth at the end of Period 2
Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways that were significantly over-represented in hepatic tissue in restricted fed animals compared with ad libitum control animals following a period of dietary restriction at the end of Period 1
| Enriched KEGG pathways | Over represented |
|---|---|
| Metabolic pathways | <0.0001 |
| Ribosome | <0.0001 |
| Steroid hormone biosynthesis | 0.0007 |
| Arginine and proline metabolism | 0.0013 |
| Glycine, serine and threonine metabolism | 0.0029 |
| Citrate cycle | 0.003 |
| Starch and sucrose metabolism | 0.0035 |
| PPAR1 signalling pathway | 0.0085 |
| Protein processing in endoplasmic reticulum | 0.010 |
| Tryptophan metabolism | 0.0212 |
| MAPK signalling pathway | 0.028 |
| Valine, leucine and isoleucine degradation | 0.029 |
| Tyrosine metabolism | 0.036 |
| Insulin signalling pathway | 0.0498 |
1 Peroxisome proliferator-activated receptor
Fig. 4Classification of differentially expressed genes according to molecular and cellular function, most significantly affected by restricted feeding in Period 1. The bars indicate the likelihood [−log (P value)] that the specific molecular and cellular function was affected by restricted feeding compared with others represented in the list of differentially expressed genes
Fig. 5Classification of differentially expressed genes according to molecular and cellular function, most significantly affected by re-alimentation in Period 2. The bars indicate the likelihood [−log (P value)] that the specific molecular and cellular function was affected by re-alimentation compared with others represented in the list of differentially expressed genes
Differentially expressed hepatic genes involved in nutrient transport in RES compared with ADLIB animals at the end of Period 1
| Gene symbol | Gene name | Fold change1 |
|
|---|---|---|---|
|
| |||
|
| Solute carrier family 36 (proton/amino acid symporter), member 1 | −1.581 | 0.00118 |
|
| Solute carrier family 38, member 2 | 1.439 | 0.00556 |
|
| Solute carrier family 38, member 4 | −1.433 | 0.00312 |
|
| Solute carrier family 6 (amino acid transporter), member 14 | 1.541 | 0.016 |
|
| Solute carrier family 7 (cationic amino acid transporter, y + system), member 2 | −2.853 |
|
|
| Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | −1.427 | 0.0043 |
|
| |||
|
| Solute carrier family 27 (fatty acid transporter), member 4 | −2.112 |
|
|
| |||
|
| Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | −9.346 |
|
|
| Solute carrier family 5 (sodium/glucose cotransporter), member 1 | −1.852 | 0.00003 |
|
| Solute carrier family 37 (glucose-6-phosphate transporter), member 4 | −1.328 | 0.0000892 |
|
| |||
|
| Solute carrier family 30, member 10 | −1.677 | 0.000127 |
|
| Solute carrier family 30 (zinc transporter), member 6 | −1.317 | 0.00204 |
|
| Solute carrier family 41 (magnesium transporter), member 2 | −1.489 | 0.000712 |
1 Fold changes are up or down in restricted fed animals compared with ad libitum control animals
Hepatic genes involved in the cell cycle differentially expressed following a period of dietary restriction (Period 1) and a subsequent period of re-alimentation and compensatory growth (Period 2)
| Gene symbol | Gene name | Fold change1 |
|
|---|---|---|---|
|
| |||
|
| Cdk5 and Abl enzyme substrate 1 | −1.589 | 0.00031 |
|
| Cell division cycle 7 | −1.251 | 0.0108 |
|
| Cyclin G2 | −1.488 | 0.000608 |
|
| Cyclin-dependent kinase 11A | −1.269 | 9.79E-05 |
|
| Cyclin-dependent kinase 12 | −1.302 | 0.000723 |
|
| Cyclin-dependent kinase 2 associated protein 1 | 1.379 | 0.0000513 |
|
| Cyclin-dependent kinase 2 associated protein 2 | 1.370 | 0.00264 |
|
| Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 1.328 | 0.0000147 |
|
| CDC28 protein kinase regulatory subunit 2 | −2.020 | 0.000000000058 |
|
| DNA-damage-inducible transcript 3 | 1.681 | 0.00000563 |
|
| Growth arrest and DNA-damage-inducible, gamma interacting protein 1 | 1.446 | 0.00019 |
|
| Leucine zipper, putative tumor suppressor 2 | 1.372 | 0.00361 |
|
| NIMA-related kinase 9 | −1.329 | 0.000193 |
|
| NUF2, NDC80 kinetochore complex component | −3.728 | 0.000000216 |
|
| |||
|
| DNA-damage-inducible transcript 3 | −1.976 | 0.0000513 |
1 Fold changes are up or down in restricted fed animals compared with ad libitum control animals
Hepatic genes involved in cell growth and proliferation differentially expressed following a period of dietary restriction (Period 1) and a subsequent period of re-alimentation and compensatory growth (Period 2)
| Gene symbol | Gene name | Fold change1 |
|
|---|---|---|---|
|
| |||
|
| Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | −1.262 | 0.00276 |
|
| Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | −1.360 | 0.00120 |
|
| Epidermal growth factor receptor | −1.428 | 0.0105 |
|
| Fibroblast growth factor receptor 4 | −1.349 | 0.000413 |
|
| Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 1.487 | 0.000464 |
|
| Inhibin, beta C | −1.759 | 0.000267 |
|
| Mesencephalic astrocyte-derived neurotrophic factor | 1.659 | 0.000717 |
|
| Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma | −1.293 | 0.0014 |
|
| Zinc finger protein 516 | −1.824 | 0.000657 |
|
| |||
|
| Mesencephalic astrocyte-derived neurotrophic factor | −2.363 | 0.000127 |
|
| Secreted protein, acidic, cysteine-rich (osteonectin) | 2.115 | 0.000257 |
1 Fold changes are up or down in restricted fed animals compared with ad libitum control animals
Fig. 6Ribosomal and protein synthesis network in hepatic tissue following dietary restriction. Merged diagram of networks 2 and 21, at the end of Period 1. Network #2: protein synthesis, RNA post-transcriptional modification. Network #21: gene expression, protein synthesis. The network is displayed graphically as nodes (genes). The node colour intensity indicates the expression of genes; with red representing up-regulation and green, down-regulation in restricted fed animals compared with ad libitum controls at the end of Period 1
Genes validated between qRT-PCR and RNAseq methodologies, including fold change (FC), P-values and correlation coefficients (R)
| RNAseq | RT-qPCR | Correlation | ||||
|---|---|---|---|---|---|---|
| Gene | FC |
| FC |
| R |
|
|
| ||||||
|
| −1.17 | 0.244 | −0.61 | 0.0924 | 0.59 | 0.052 |
|
| 1.15 | 0.227 | 0.71 | 0.602 | 0.61 | 0.044 |
|
| −1.07 | 0.576 | −0.69 | 1 | 0.57 | 0.031 |
|
| −2.53 | <.0001 | −1.06 | 0.001 | 0.48 | 0.013 |
|
| 3.62 | <.0001 | 3.91 | <.0001 | 0.95 | <0.001 |
|
| 29.25 | <.0001 | 8.45 | <.0001 | 0.52 | 0.008 |
|
| −1.11 | 0.139 | −0.84 | 0.684 | 0.63 | 0.045 |
|
| 1.01 | 0.952 | 0.65 | 0.872 | 0.51 | 0.094 |
|
| −1.48 | 0.401 | −1.13 | 0.999 | 0.70 | 0.012 |
|
| 1.83 | <.0001 | 1.74 | <.0001 | 0.65 | 0.023 |
|
| 1.05 | 0.641 | 1.02 | 0.648 | 0.82 | 0.037 |
|
| −1.89 | <.0001 | −1.39 | 0.0274 | 0.77 | 0.048 |
|
| ||||||
|
| 1.05 | 0.722 | 0.065 | 0.963 | 0.49 | 0.089 |
|
| 1.13 | 0.339 | 0.75 | 0.641 | 0.63 | 0.054 |
|
| 1.09 | 0.466 | 0.62 | 0.999 | 0.48 | 0.036 |
|
| −1.01 | 0.914 | −0.76 | 0.995 | 0.72 | 0.037 |
|
| 1.29 | 0.032 | 1.00 | 0.043 | 0.81 | 0.002 |
|
| 1.04 | 0.755 | 0.51 | 0.910 | 0.59 | 0.054 |
|
| 1.05 | 0.669 | 0.58 | 0.979 | 0.29 | 0.068 |
|
| −1.04 | 0.731 | −0.83 | 0.993 | 0.42 | 0.047 |
|
| 1.33 | 0.051 | 1.00 | 0.495 | 0.16 | 0.054 |
|
| −1.23 | 0.625 | −0.77 | 0.990 | 0.57 | 0.024 |
|
| −1.01 | 0.955 | −0.88 | 1 | 0.49 | 0.078 |
|
| 1.03 | 0.048 | 1.09 | 0.041 | 0.86 | 0.025 |